SEC Form 4 · accession 0001567619-19-002514
MCDONALDS CORP · MCD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Ogden Fairhurst
Officer — EVP & Chief People Officer
Period of report
Feb 5, 2019
Accepted (ET)
Feb 6, 2019 · 3:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000063908
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 5, 2019 | M | 8,962 | $63.25 | A | 12,110 | D | |
| Common Stock | Feb 5, 2019 | M | 8,298 | $75.93 | A | 20,408 | D | |
| Common Stock | Feb 5, 2019 | M | 9,796 | $100.05 | A | 30,204 | D | |
| Common Stock | Feb 5, 2019 | M | 7,979 | $94.00 | A | 38,183 | D | |
| Common Stock | Feb 5, 2019 | M | 8,695 | $94.89 | A | 46,878 | D | |
| Common Stock | Feb 5, 2019 | M | 7,946 | $97.15 | A | 54,824 | D | |
| Common Stock | Feb 5, 2019 | M | 15,349 | $116.73 | A | 70,173 | D | |
| Common Stock | Feb 5, 2019 | M | 9,386 | $128.09 | A | 79,559 | D | |
| Common StockF1 | Feb 5, 2019 | S | 76,411 | $178.25 | D | 3,148 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options (Right to Buy)F2 | $63.25 | Feb 5, 2019 | M | 8,962 | D | — | Feb 10, 2020 | Common Stock | 8,962 | 0 | D |
| Options (Right to Buy)F2 | $75.93 | Feb 5, 2019 | M | 8,298 | D | — | Feb 9, 2021 | Common Stock | 8,298 | 0 | D |
| Options (Right to Buy)F2 | $100.05 | Feb 5, 2019 | M | 9,796 | D | — | Feb 8, 2022 | Common Stock | 9,796 | 0 | D |
| Options (Right to Buy)F2 | $94.00 | Feb 5, 2019 | M | 7,979 | D | — | Feb 13, 2023 | Common Stock | 7,979 | 0 | D |
| Options (Right to Buy)F2 | $94.89 | Feb 5, 2019 | M | 791 | D | — | Feb 12, 2024 | Common Stock | 791 | 0 | D |
| Options (Right to Buy)F2 | $94.89 | Feb 5, 2019 | M | 7,904 | D | — | Feb 12, 2024 | Common Stock | 7,904 | 0 | D |
| Options (Right to Buy)F2 | $97.15 | Feb 5, 2019 | M | 7,946 | D | — | Mar 16, 2025 | Common Stock | 7,946 | 2,648 | D |
| Options (Right to Buy)F2 | $116.73 | Feb 5, 2019 | M | 15,349 | D | — | Feb 11, 2026 | Common Stock | 15,349 | 15,348 | D |
| Options (Right to Buy)F2 | $128.09 | Feb 5, 2019 | M | 9,386 | D | — | Mar 8, 2027 | Common Stock | 9,386 | 28,152 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $178.00 to $179.39 per share. The price reported represents the weighted average sales price of these trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price.
- F2Options become exercisable in 25% increments on the first, second, third and fourth anniversary dates of the grant.